SuperCom (NASDAQ:SPCB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of SuperCom (NASDAQ:SPCB) in a research report report published on Saturday morning. The brokerage issued a sell rating on the industrial products company’s stock.

SuperCom Trading Down 6.9 %

NASDAQ:SPCB opened at $0.37 on Friday. The company has a debt-to-equity ratio of 5.46, a quick ratio of 7.53 and a current ratio of 8.31. SuperCom has a one year low of $0.15 and a one year high of $1.54. The business’s 50-day simple moving average is $0.19 and its 200 day simple moving average is $0.31. The stock has a market cap of $2.24 million, a price-to-earnings ratio of -0.73 and a beta of 0.27.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. UBS Group AG acquired a new stake in SuperCom during the first quarter valued at approximately $37,000. Virtu Financial LLC grew its holdings in shares of SuperCom by 126.2% during the first quarter. Virtu Financial LLC now owns 90,927 shares of the industrial products company’s stock valued at $52,000 after purchasing an additional 50,735 shares during the last quarter. Citadel Advisors LLC bought a new position in shares of SuperCom during the fourth quarter valued at approximately $63,000. Finally, Armistice Capital LLC bought a new position in shares of SuperCom during the first quarter valued at approximately $673,000. Institutional investors and hedge funds own 47.81% of the company’s stock.

About SuperCom

SuperCom Ltd. provides digital identity, Internet of Things and connectivity, and cyber security products and solutions to governments, and private and public organizations worldwide. The company operates in three segments: e-Gov, IoT and Connectivity, and Cyber Security. It offers MAGNA, a platform for national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management.